These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9501606)

  • 1. [Treatment of rhythmic and thromboembolic complications of cardiac failure].
    Bounhoure JP; Varnous S; Galinier M
    Rev Prat; 1997 Dec; 47(19):2135-8. PubMed ID: 9501606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of arrhythmias in patients with heart failure].
    Le Heuzey JY; Copie X; Piot O; Lavergne T; Henry P; Guize L
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1371-6. PubMed ID: 9864606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ventricular arrhythmias in heart failure: drugs or devices.
    Gambhir DS
    Indian Heart J; 1998; 50(5):507-10. PubMed ID: 10052273
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of complications: a forgotten aspect of therapy? arrhythmia complication in heart failure].
    de Sousa J
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():33-8. PubMed ID: 11409072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of statins in heart failure.
    Sandesara CM; Roodneshin H; Sbaity S; Olshansky B
    Heart Fail Clin; 2008 Apr; 4(2):187-200. PubMed ID: 18433699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arrhythmia risk stratification in patients with heart failure. Foreword].
    Opasich C; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
    Disertori M; Dallafior D; Marini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The problem of sudden death in heart failure].
    Delise P; Sciarra L
    Ital Heart J; 2005 May; 6 Suppl 1():24S-33S. PubMed ID: 15945297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of ventricular arrhythmia in chronic congestive heart failure].
    Pulignano G; Giovannini M; Del Sindaco D; Fera MS; Mazza A; Minardi G; Giovannini E
    Clin Ter; 1998; 149(4):297-305. PubMed ID: 9866892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of invasive electrophysiology in the management of patients with chronic heart failure.
    Landolina M; Cantù F; De Ferrari GM; Foresti S; Tavazzi L
    Heart Fail Monit; 2002; 3(2):49-59. PubMed ID: 12634880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac insufficiency: prevention of ventricular arrhythmias].
    Mabo P; Leclercq C; Pavin D
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug therapy in patients with renal failure, liver failure, and congestive heart failure.
    Chow T; Galvin J; McGovern B
    Heart Dis; 1999; 1(2):98-107. PubMed ID: 11720610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification.
    Piepoli MF; Capucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications.
    Dotsenko O; Kakkar VV
    J Thromb Haemost; 2007 Feb; 5(2):224-31. PubMed ID: 17067363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.